Faculty disclosure

The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

José Bellver-Pradas
Manuel Fernández-Sánchez
Pietro Gambadauro
Juan Antonio Garcia Velasco
Elkin Albeiro Muñoz
Antonio Pellicer
José Antonio Remohí Giménez
Antonio Requena Miranda
José Serna Lopez
Sérgio Reis Soares

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

Ernesto Bosch Aparicio: Declared receipts of honoraria or consultation fees from Schering Plough and Merck Serono.

Carlos Simón: Declared receipts of grants and contracts from the Spanish and Valencia Governments and to be member of StemLifeLine and Igenomix Advisory Boards but declared that this does not represent a potential conflict of interest.

Iván Martin Valencia Llerena: Declared that his presentation will include data on investigational use of drugs not approved by EMEA and/or FDA in the indications mentioned.